Urovant Sciences Ltd. (26) | Business Operations (6)

Browse by Subcategory

Recent Contracts

First Amendment to Market Access Services Agreement, dated December 21, 2020, by and between the Company and Sunovion Pharmaceuticals, Inc (Filed With SEC on February 12, 2021)
Voting and Support Agreement, dated as of November 12, 2020, between Urovant Sciences Ltd. and Sumitovant Biopharma Ltd (Filed With SEC on November 13, 2020)
Information Sharing and Cooperation Agreement, dated May 21, 2020, by and between Urovant Sciences, Ltd. and Sumitovant Biopharma Ltd (Filed With SEC on May 28, 2020)
Form of Indemnification Agreement with officers and directors (Filed With SEC on April 6, 2020)
Second Amendment to Market Access Services Agreement, dated January 8, 2021, by and between the Company and Sunovion Pharmaceuticals, Inc (Filed With SEC on February 12, 2021)
Market Access Services Agreement, dated June 17, 2020, by and between the Company and Sunovion Pharmaceuticals Inc (Filed With SEC on August 13, 2020)